ALNYBiotechnology / Biotechnology
Alnylam Pharmaceuticals Inc
30-Day Price
Key Metrics
Latest Close
$312.17
Market Cap
$41.3B
Shares Outstanding
132,620,000
P/E Ratio
131.71
P/B Ratio
66.57
ROE
3976.00%
ROA
632.00%
Gross Margin
8164.00%
Operating Margin
1236.00%
Net Margin
845.00%
Debt / Equity
3.42
Current Ratio
2.76
Want the full picture?
Sign up free for full analysis, strategy backtesting with credibility scoring, portfolio management, and more.
Start Free